Literature DB >> 16127454

Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.

Romain Roncagalli1, James E R Taylor, Shaohua Zhang, Xiaochu Shi, Riyan Chen, Mario-Ernesto Cruz-Munoz, Luo Yin, Sylvain Latour, André Veillette.   

Abstract

EAT-2 is an adaptor expressed in innate immune cells, including natural killer (NK) cells. It is closely related to the adaptor SAP, which regulates signaling lymphocyte activation molecule (SLAM)-related receptors by recruiting the kinase FynT to the receptors. Here we have studied the function of EAT-2 in NK cells by creating mice lacking or overexpressing EAT-2. Like SAP, EAT-2 was associated with the SLAM-related receptor 2B4 in NK cells. However, unlike SAP, EAT-2 was an inhibitor of NK cell function. EAT-2 repressed natural cytotoxicity and interferon-gamma secretion by a mechanism involving tyrosine phosphorylation of its C terminus. We have demonstrated a similar function for the adaptor ERT, a newly identified SAP family member expressed in mouse NK cells. These data identify a previously unknown mechanism of NK cell inhibition. Moreover, they indicate that EAT-2 and SAP have distinct and at times opposing functions in natural immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127454     DOI: 10.1038/ni1242

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  52 in total

Review 1.  Current perspectives of natural killer cell education by MHC class I molecules.

Authors:  Petter Höglund; Petter Brodin
Journal:  Nat Rev Immunol       Date:  2010-09-06       Impact factor: 53.106

2.  A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.

Authors:  Ning Wu; Ming-Chao Zhong; Romain Roncagalli; Luis-Alberto Pérez-Quintero; Huaijian Guo; Zhanguang Zhang; Christelle Lenoir; Zhongjun Dong; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

Review 3.  PD-1 signaling in primary T cells.

Authors:  James L Riley
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  Lymphocytes in action. Symposium on Lymphocyte Activation and Signalling.

Authors:  Woong-Kyung Suh; Jayanta Chaudhuri
Journal:  EMBO Rep       Date:  2008-09       Impact factor: 8.807

5.  Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function.

Authors:  Mario-Ernesto Cruz-Munoz; Zhongjun Dong; Xiaochu Shi; Shaohua Zhang; André Veillette
Journal:  Nat Immunol       Date:  2009-01-18       Impact factor: 25.606

6.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

7.  Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells.

Authors:  Zhongjun Dong; Mario-Ernesto Cruz-Munoz; Ming-Chao Zhong; Riyan Chen; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

Review 8.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 9.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.

Authors:  Juan Liu; Shuxun Liu; Meng Xia; Sheng Xu; Chunmei Wang; Yan Bao; Minghong Jiang; Yue Wu; Tian Xu; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.